HUP0001286A3 - Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs - Google Patents

Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs

Info

Publication number
HUP0001286A3
HUP0001286A3 HU0001286A HUP0001286A HUP0001286A3 HU P0001286 A3 HUP0001286 A3 HU P0001286A3 HU 0001286 A HU0001286 A HU 0001286A HU P0001286 A HUP0001286 A HU P0001286A HU P0001286 A3 HUP0001286 A3 HU P0001286A3
Authority
HU
Hungary
Prior art keywords
dogs
inflammation
pharmaceutical composition
acetic acid
composition containing
Prior art date
Application number
HU0001286A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUP0001286A2 publication Critical patent/HUP0001286A2/hu
Publication of HUP0001286A3 publication Critical patent/HUP0001286A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
HU0001286A 1997-05-05 1998-05-01 Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs HUP0001286A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (2)

Publication Number Publication Date
HUP0001286A2 HUP0001286A2 (hu) 2000-11-28
HUP0001286A3 true HUP0001286A3 (en) 2000-12-28

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001286A HUP0001286A3 (en) 1997-05-05 1998-05-01 Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (ko)
JP (1) JP2000513020A (ko)
KR (2) KR20040004406A (ko)
CN (1) CN1255059A (ko)
AP (1) AP9801234A0 (ko)
AR (2) AR011726A1 (ko)
AU (1) AU6932198A (ko)
BG (1) BG103852A (ko)
BR (1) BR9808720A (ko)
CA (1) CA2288759A1 (ko)
DZ (1) DZ2479A1 (ko)
EA (1) EA003696B1 (ko)
GT (1) GT199800063A (ko)
HR (1) HRP980244A2 (ko)
HU (1) HUP0001286A3 (ko)
ID (1) ID21311A (ko)
IL (1) IL132570A0 (ko)
IS (1) IS5220A (ko)
MA (1) MA26491A1 (ko)
NO (1) NO995389L (ko)
NZ (1) NZ500183A (ko)
OA (1) OA11213A (ko)
PA (1) PA8450601A1 (ko)
PE (1) PE72599A1 (ko)
PL (1) PL337003A1 (ko)
SK (1) SK148199A3 (ko)
TN (1) TNSN98059A1 (ko)
TW (1) TW590773B (ko)
UY (1) UY24989A1 (ko)
WO (1) WO1998050033A1 (ko)
YU (1) YU55899A (ko)
ZA (1) ZA983722B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
WO2000053149A2 (en) * 1999-03-10 2000-09-14 G.D. Searle & Co. Method and composition for administering a cyclooxygenase-2 inhibitor
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
CA2407469A1 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
US6924303B2 (en) 2000-06-13 2005-08-02 Wyeth Analgesic and anti-inflammatory compositions containing COX-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
ATE421595T1 (de) 2000-08-07 2009-02-15 Univ Vanderbilt Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2- arachidonylglycerin-metaboliten
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
DE602004002832T2 (de) 2003-05-07 2007-06-06 Osteologix A/S Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
CN1829510A (zh) * 2003-07-31 2006-09-06 法马西亚和厄普乔恩公司 抗炎剂的可分散性制剂
CA2608010A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
US9114071B2 (en) 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
WO2010133609A2 (en) 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
PL3113774T3 (pl) 2014-03-06 2022-06-13 Elanco Animal Health Incorporated Kompozycje grapiprantu i sposoby ich zastosowania
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
CA2972996A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
EP4125874A4 (en) * 2020-03-25 2024-05-01 SRI International LIPOXYGENASE INHIBITORS
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
JP2000513020A (ja) 2000-10-03
TNSN98059A1 (fr) 2005-03-15
SK148199A3 (en) 2001-09-11
ID21311A (id) 1999-05-20
CN1255059A (zh) 2000-05-31
NO995389D0 (no) 1999-11-04
BG103852A (en) 2000-06-30
KR20010012300A (ko) 2001-02-15
EA003696B1 (ru) 2003-08-28
EP0988034A1 (en) 2000-03-29
CA2288759A1 (en) 1998-11-12
AU6932198A (en) 1998-11-27
WO1998050033A1 (en) 1998-11-12
NZ500183A (en) 2002-04-26
IS5220A (is) 1999-10-19
HRP980244A2 (en) 1999-02-28
BR9808720A (pt) 2000-07-11
GT199800063A (es) 1999-10-26
PA8450601A1 (es) 2000-05-24
ZA983722B (en) 1999-11-04
DZ2479A1 (fr) 2003-02-01
NO995389L (no) 2000-01-04
AR011726A1 (es) 2000-08-30
TW590773B (en) 2004-06-11
EA199900895A1 (ru) 2000-06-26
KR20040004406A (ko) 2004-01-13
AR039628A2 (es) 2005-03-02
IL132570A0 (en) 2001-03-19
AP9801234A0 (en) 1999-11-04
MA26491A1 (fr) 2004-12-20
HUP0001286A2 (hu) 2000-11-28
PL337003A1 (en) 2000-07-31
PE72599A1 (es) 1999-08-12
YU55899A (sh) 2003-08-29
OA11213A (en) 2003-07-14
UY24989A1 (es) 2001-10-25

Similar Documents

Publication Publication Date Title
HUP0001286A3 (en) Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
EP0858334A4 (en) IMMEDIATE AND SLOW RELEASE ANALGESIC PHARMACEUTICAL COMPOSITION
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
HUP0202338A3 (en) Pharmaceutical composition containing fenofibrate and preparation method
AU1534899A (en) Device and method for non-occlusive localized drug delivery
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
HK1029914A1 (en) Device and pharmaceutical agent for treatment of dysmenorrhea
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
GB2331247B (en) Improvements in relation to apparatus for surgical diathermy
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
EP1003523A4 (en) COMPILATION AND TREATMENT METHOD OF LIVER TUMORS
IL133784A (en) Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer
PL344246A1 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
AU4224600A (en) Composition and method for treatment of inflammation and pain in mammals
IL131229A0 (en) Compounds and methods for therapeutic intervention in preventing diabetic complications
HK1015351A1 (en) Substituted amino compounds and their use as analgesic active substances
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
NO20000371L (no) Aminoetylfenoksyeddiksyrederivater og legemidler for smertereduksjon og kalksteinfjerningsfremming i urin litiasis
AU7793791A (en) Pharmaceutical composition for use in treating pain
AU1026399A (en) Pharmaceutical compositions containing ricinoleic acid and their use in anti-inflammatory and analgesic therapy
SG65766A1 (en) Composition for preventing and treating gingival diseases
EP0987942A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE